\-\ Texto\\:\\ \ \(0\)\
\-\ left\\ lower\\ extremity\\ tenderness\\ on\\ physical\\ exam\\.\\ \\ \ \(0\)\
\-\ pertinent\\ laboratory\\:\\ \ \(0\)\
\-\ wbc\\ 6\\.8\\ cells\\/mm3\\.\\ \ \(0\)\
\-\ normal\\ inr\\,\\ pt\\,\\ and\\ aptt\ \(0\)\
\-\ cmp\\ wnl\ \(0\)\
\-\ idiopathic\\ osteonecrosis\\ lesions\\ are\\ treated\\ conservatively\\,\\ and\\ this\\ man\\ was\\ given\\ analgesics\\ for\\ pain\\ with\\ close\\ follow\\-up\\ appointments\\ for\\ observation\\.\\ \\ in\\ the\\ event\\ of\\ progression\\,\\ surgical\\ intervention\\ may\\ be\\ required\\.\ \(0\)\
\-\ initial\\ plain\\ film\\ lateral\\ and\\ oblique\\ radiographs\\ of\\ left\\ ankle\\ demonstrate\\ central\\ medullary\\ hypodensities\\ in\\ distal\\ tibial\\ shaft\\ and\\ metadiaphysis\\.\ \(0\)\
\-\ mri\\ left\\ ankle\\ with\\ sagittal\\ t1\\ and\\ sagittal\\ stir\\ images\\ shows\\ diffuse\\ pattern\\ of\\ marrow\\ edema\\ isolated\\ to\\ distal\\ tibia\\ extending\\ to\\ tibial\\ plafond\\.\\ \\ proximal\\ extent\\ of\\ the\\ marrow\\ edema\\ is\\ not\\ visualized\\.\ \(0\)\
\-\ noncontrast\\ ct\\ of\\ left\\ lower\\ extremity\\ was\\ acquired\\ as\\ the\\ superior\\ extent\\ of\\ tibial\\ involvement\\ was\\ not\\ able\\ to\\ be\\ visualized\\ on\\ mri\\ ankle\\.\\ \\ it\\ shows\\ heterogeneous\\ appearance\\ of\\ medullary\\ space\\ throughout\\ tibia\\ and\\ visualized\\ portion\\ of\\ distal\\ femur\\.\\ \\ no\\ periosteal\\ reaction\\.\ \(0\)\
\-\ whole\\ body\\ tc99\\ bone\\ scan\\ \\(delayed\\ imaging\\)\\ demonstrates\\ diffuse\\ increased\\ uptake\\ in\\ left\\ tibia\\ with\\ increased\\ uptake\\ also\\ seen\\ in\\ distal\\ femur\\.\\ \ \(0\)\
\-\ mri\\ of\\ the\\ left\\ lower\\ extremity\\ for\\ the\\ mid\\ femur\\ to\\ the\\ ankle\\ demonstrates\\ circumscribed\\ geographic\\ lesions\\ in\\ distal\\ femur\\ and\\ proximal\\ tibia\\ central\\ marrow\\ that\\ demonstrate\\ low\\ t1\\ signal\\ and\\ peripheral\\ enhancement\\ with\\ heterogenous\\ high\\ signal\\ on\\ stir\\ sequences\\.\\ \\ no\\ abnormal\\ soft\\ tissue\\ fluid\\ collections\\ are\\ noted\\.\ \(0\)\
\-\ osteonecrosis\ \(57\)\
\-\ 1\\.\\ osteonecrosis\ \(0\)\
\-\ 2\\.\\ osteomyelitis\ \(0\)\
\-\ 3\\.\\ stress\\ injury\ \(0\)\
\-\ 4\\.\\ enchondroma\\ \\(based\\ on\\ plain\\ film\\)\ \(0\)\
\-\ 26\\ y\\/o\\ man\\ presents\\ to\\ orthopedic\\ clinic\\ with\\ localized\\ left\\ lower\\ extremity\\ pain\\ not\\ relieved\\ with\\ pain\\ medications\\.\\ \\ he\\ has\\ had\\ no\\ recent\\ trauma\\ or\\ surgeries\\ in\\ the\\ left\\ lower\\ extremity\\.\ \(0\)\
\-\ he\\ was\\ involved\\ in\\ an\\ mva\\ trauma\\ 17\\ months\\ previously\\ in\\ which\\ he\\ developed\\ left\\ foot\\ and\\ ankle\\ pain\\ and\\ swelling\\.\\ \\ mri\\ at\\ the\\ time\\ demonstrated\\ bone\\ marrow\\ edema\\ and\\ left\\ hindfoot\\ lesions\\.\\ he\\ was\\ placed\\ on\\ two\\ week\\ oral\\ steroid\\ course\\ and\\ the\\ pain\\ and\\ swelling\\ resolved\\ over\\ the\\ following\\ year\\.\\ \\ \ \(0\)\
\-\ four\\ months\\ after\\ his\\ initial\\ trauma\\,\\ \\ he\\ developed\\ acute\\ pancreatitis\\ and\\ pancreatic\\ pseudocysts\\ secondary\\ to\\ traumatic\\ pancreatic\\ duct\\ rupture\\.\ \(0\)\
\-\ this\\ patient\\ demonstrates\\ typical\\ findings\\ of\\ osteonecrosis\\ on\\ plain\\ film\\,\\ bone\\ scan\\,\\ and\\ mr\\.\\ \\ on\\ radiography\\,\\ there\\ are\\ typical\\ findings\\ to\\ include\\ well\\-defined\\ subchondral\\ lucencies\\ with\\ background\\ bone\\ sclerosis\\.\\ \\ on\\ bone\\ scan\\,\\ increased\\ uptake\\ of\\ radiotracers\\ indicative\\ of\\ repair\\ process\\ is\\ noted\\.\\ \\ \ \(0\)\
\-\ on\\ mr\\,\\ geographic\\ t1\\ hypointensity\\ and\\ t2\\ hyperintensity\\ in\\ involved\\ areas\\ representing\\ bone\\ marrow\\ edema\\ and\\ necrosis\\.\\ \ \(0\)\
\-\ his\\ clinical\\ course\\ began\\ one\\ month\\ after\\ his\\ trauma\\.\\ \\ the\\ trauma\\ may\\ have\\ been\\ the\\ inciting\\ factor\\ for\\ his\\ osteonecrosis\\.\\ \\ as\\ pancreatitis\\ is\\ a\\ known\\ risk\\ factor\\ for\\ osteonecrosis\\,\\ this\\ may\\ have\\ contributed\\.\\ \\ pancreatitis\\ can\\ cause\\ fatty\\ emboli\\ to\\ occlude\\ the\\ vasculature\\ supplying\\ the\\ involved\\ area\\.\\ \\ \ \(0\)\
\-\ the\\ involved\\ osteonecrotic\\ areas\\ of\\ his\\ left\\ lower\\ extremity\\ are\\ currently\\ being\\ monitored\\ for\\ progression\\,\\ as\\ complications\\ can\\ include\\ fracture\\ and\\/or\\ collapse\\ of\\ the\\ osseous\\ structures\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteonecrosis\\:\\ 0\\.062373561610400204\ \(0\)\
\-\ ankle\\:\\ 0\\.04022318473916253\ \(0\)\
\-\ marrow\\:\\ 0\\.0371469626345671\ \(0\)\
\-\ extremity\\:\\ 0\\.03705722098390242\ \(0\)\
\-\ tibia\\:\\ 0\\.031029006290472286\ \(0\)\
\-\ femur\\:\\ 0\\.029182248573622442\ \(0\)\
\-\ involved\\:\\ 0\\.02833525539218902\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.027796743313763278\ \(0\)\
\-\ bone\\:\\ 0\\.025179067369089366\ \(0\)\
\-\ his\\:\\ 0\\.024336848099277983\ \(0\)\
\-\ he\\:\\ 0\\.023559163458824302\ \(0\)\
\-\ tibial\\:\\ 0\\.023407019605795942\ \(0\)\
\-\ geographic\\:\\ 0\\.023205847607905367\ \(0\)\
\-\ trauma\\:\\ 0\\.023092972151758193\ \(0\)\
\-\ distal\\:\\ 0\\.022957298309743347\ \(0\)\
\-\ lower\\:\\ 0\\.022788878292852123\ \(0\)\
\-\ stir\\:\\ 0\\.021966094410849863\ \(0\)\
\-\ left\\:\\ 0\\.02078489715810684\ \(0\)\
\-\ visualized\\:\\ 0\\.020507502861429754\ \(0\)\
\-\ uptake\\:\\ 0\\.020128360225459753\ \(0\)\
\-\ film\\:\\ 0\\.019459262461891173\ \(0\)\
\-\ edema\\:\\ 0\\.01910611454095882\ \(0\)\
\-\ tc99\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ factor\\:\\ 0\\.01723783054432012\ \(0\)\
\-\ progression\\:\\ 0\\.016803044397227913\ \(0\)\
\-\ extent\\:\\ 0\\.016762084764676343\ \(0\)\
\-\ pancreatic\\:\\ 0\\.01652485942978997\ \(0\)\
\-\ plain\\:\\ 0\\.016454132683927376\ \(0\)\
\-\ medullary\\:\\ 0\\.016229202461083652\ \(0\)\
\-\ t1\\:\\ 0\\.01605827393018326\ \(0\)\
\-\ mri\\:\\ 0\\.015519967232526638\ \(0\)\
\-\ cells\\/mm3\\:\\ 0\\.01525080263892962\ \(0\)\
\-\ radiotracers\\:\\ 0\\.01525080263892962\ \(0\)\
\-\ osteonecrotic\\:\\ 0\\.01525080263892962\ \(0\)\
\-\ 6\\.8\\:\\ 0\\.014241265833067979\ \(0\)\
\-\ aptt\\:\\ 0\\.014241265833067979\ \(0\)\
\-\ plafond\\:\\ 0\\.014241265833067979\ \(0\)\
\-\ scan\\:\\ 0\\.014183427631025564\ \(0\)\
\-\ hindfoot\\:\\ 0\\.013880946550866488\ \(0\)\
\-\ pseudocysts\\:\\ 0\\.013880946550866488\ \(0\)\
\-\ occlude\\:\\ 0\\.013576300938559653\ \(0\)\
\-\ lesions\\:\\ 0\\.013562611697691388\ \(0\)\
\-\ typical\\:\\ 0\\.013543267565810266\ \(0\)\
\-\ sagittal\\:\\ 0\\.013471725899234701\ \(0\)\
\-\ appointments\\:\\ 0\\.013312404905704865\ \(0\)\
\-\ developed\\:\\ 0\\.013004211402508752\ \(0\)\
\-\ on\\:\\ 0\\.012875531840491805\ \(0\)\
\-\ course\\:\\ 0\\.012745183570970913\ \(0\)\
\-\ hypodensities\\:\\ 0\\.012683049705865864\ \(0\)\
\-\ inciting\\:\\ 0\\.012511090462803354\ \(0\)\
\-\ increased\\:\\ 0\\.012394178548219302\ \(0\)\
\-\ supplying\\:\\ 0\\.012352903293488064\ \(0\)\
\-\ metadiaphysis\\:\\ 0\\.011822737312075655\ \(0\)\
\-\ contributed\\:\\ 0\\.011822737312075655\ \(0\)\
\-\ areas\\:\\ 0\\.011365008582000263\ \(0\)\
\-\ swelling\\:\\ 0\\.011252216853680365\ \(0\)\
\-\ analgesics\\:\\ 0\\.011225344284658791\ \(0\)\
\-\ initial\\:\\ 0\\.011192024281736395\ \(0\)\
\-\ central\\:\\ 0\\.01111316741841881\ \(0\)\
\-\ may\\:\\ 0\\.011112618787933539\ \(0\)\
\-\ demonstrates\\:\\ 0\\.011066924120473434\ \(0\)\
\-\ background\\:\\ 0\\.011060558496241693\ \(0\)\
\-\ cmp\\:\\ 0\\.010908461577000334\ \(0\)\
\-\ mr\\:\\ 0\\.010732013723108435\ \(0\)\
\-\ hypointensity\\:\\ 0\\.010700239214040203\ \(0\)\
\-\ inr\\:\\ 0\\.010572692729578599\ \(0\)\
\-\ pain\\:\\ 0\\.01031233367125232\ \(0\)\
\-\ diffuse\\:\\ 0\\.010225325772234445\ \(0\)\
\-\ monitored\\:\\ 0\\.010181732762523422\ \(0\)\
\-\ proximal\\:\\ 0\\.01014048688421745\ \(0\)\
\-\ lucencies\\:\\ 0\\.01013169756887858\ \(0\)\
\-\ enchondroma\\:\\ 0\\.010035274319531875\ \(0\)\
\-\ surgeries\\:\\ 0\\.010035274319531875\ \(0\)\
\-\ shaft\\:\\ 0\\.009988771360223192\ \(0\)\
\-\ whole\\:\\ 0\\.009943337529739598\ \(0\)\
\-\ relieved\\:\\ 0\\.009943337529739598\ \(0\)\
\-\ was\\:\\ 0\\.009765588164166866\ \(0\)\
\-\ indicative\\:\\ 0\\.009651566781111011\ \(0\)\
\-\ radiography\\:\\ 0\\.0096131911173618\ \(0\)\
\-\ pertinent\\:\\ 0\\.009502342369039579\ \(0\)\
\-\ include\\:\\ 0\\.009474914972451726\ \(0\)\
\-\ conservatively\\:\\ 0\\.00939738223996063\ \(0\)\
\-\ event\\:\\ 0\\.00933038312597707\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.009297716521330409\ \(0\)\
\-\ shows\\:\\ 0\\.009286062054264342\ \(0\)\
\-\ months\\:\\ 0\\.009225064405889593\ \(0\)\
\-\ are\\:\\ 0\\.009208489110905943\ \(0\)\
\-\ vasculature\\:\\ 0\\.009172195956661779\ \(0\)\
\-\ emboli\\:\\ 0\\.009142023086838086\ \(0\)\
\-\ collections\\:\\ 0\\.009083025135949389\ \(0\)\
\-\ acquired\\:\\ 0\\.009054173753694147\ \(0\)\
\-\ noncontrast\\:\\ 0\\.009025737513670234\ \(0\)\
\-\ steroid\\:\\ 0\\.008915915673443336\ \(0\)\
\-\ signal\\:\\ 0\\.008905432135465527\ \(0\)\
\-\ subchondral\\:\\ 0\\.008863211627826417\ \(0\)\
\-\ isolated\\:\\ 0\\.008786700734188689\ \(0\)\
\-\ fatty\\:\\ 0\\.008761841480815446\ \(0\)\
\-\ representing\\:\\ 0\\.008713041851190206\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.008689086593221146\ \(0\)\
\-\ wnl\\:\\ 0\\.008665418231468743\ \(0\)\
\-\ observation\\:\\ 0\\.008665418231468743\ \(0\)\
\-\ heterogenous\\:\\ 0\\.008665418231468743\ \(0\)\
\-\ for\\:\\ 0\\.008645551169676463\ \(0\)\
\-\ collapse\\:\\ 0\\.00864202997524937\ \(0\)\
\-\ began\\:\\ 0\\.008551150304810984\ \(0\)\
\-\ mva\\:\\ 0\\.008401522198613957\ \(0\)\
\-\ close\\:\\ 0\\.008243335029298667\ \(0\)\
\-\ localized\\:\\ 0\\.008224423070768726\ \(0\)\
\-\ 17\\:\\ 0\\.008224423070768726\ \(0\)\
\-\ resolved\\:\\ 0\\.008187133576096031\ \(0\)\
\-\ orthopedic\\:\\ 0\\.008061897184924905\ \(0\)\
\-\ periosteal\\:\\ 0\\.008010562231558778\ \(0\)\
\-\ noted\\:\\ 0\\.008005617345662425\ \(0\)\
\-\ man\\:\\ 0\\.007987872897588929\ \(0\)\
\-\ able\\:\\ 0\\.007960527037913938\ \(0\)\
\-\ oblique\\:\\ 0\\.007848480904165824\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.007848480904165824\ \(0\)\
\-\ 26\\:\\ 0\\.007817600829258548\ \(0\)\
\-\ demonstrate\\:\\ 0\\.007772538108035734\ \(0\)\
\-\ duct\\:\\ 0\\.00774244787354859\ \(0\)\
\-\ idiopathic\\:\\ 0\\.007698690707783346\ \(0\)\
\-\ reaction\\:\\ 0\\.007670048400861277\ \(0\)\
\-\ as\\:\\ 0\\.0076635029993722984\ \(0\)\
\-\ can\\:\\ 0\\.007660957914897508\ \(0\)\
\-\ clinic\\:\\ 0\\.0075460595853802034\ \(0\)\
\-\ medications\\:\\ 0\\.007532751221385452\ \(0\)\
\-\ intervention\\:\\ 0\\.007519531877213917\ \(0\)\
\-\ circumscribed\\:\\ 0\\.00750640036986477\ \(0\)\
\-\ in\\:\\ 0\\.007495207650715997\ \(0\)\
\-\ stress\\:\\ 0\\.007404375932304874\ \(0\)\
\-\ four\\:\\ 0\\.007331171838074935\ \(0\)\
\-\ not\\:\\ 0\\.007321059318628075\ \(0\)\
\-\ have\\:\\ 0\\.007313984499466766\ \(0\)\
\-\ findings\\:\\ 0\\.007189078797588773\ \(0\)\
\-\ rupture\\:\\ 0\\.007170222565465895\ \(0\)\
\-\ osseous\\:\\ 0\\.007170222565465895\ \(0\)\
\-\ and\\/or\\:\\ 0\\.007137374974090321\ \(0\)\
\-\ oral\\:\\ 0\\.007115776020469392\ \(0\)\
\-\ previously\\:\\ 0\\.007094410573623117\ \(0\)\
\-\ traumatic\\:\\ 0\\.00707327363860978\ \(0\)\
\-\ mid\\:\\ 0\\.0070627893456657225\ \(0\)\
\-\ sequences\\:\\ 0\\.007052360379063265\ \(0\)\
\-\ after\\:\\ 0\\.006988147045886175\ \(0\)\
\-\ foot\\:\\ 0\\.006980859081479268\ \(0\)\
\-\ delayed\\:\\ 0\\.006873478941235533\ \(0\)\
\-\ placed\\:\\ 0\\.006835834287143252\ \(0\)\
\-\ repair\\:\\ 0\\.006762630192913313\ \(0\)\
\-\ to\\:\\ 0\\.006752064955620336\ \(0\)\
\-\ currently\\:\\ 0\\.006692041096861773\ \(0\)\
\-\ complications\\:\\ 0\\.006692041096861773\ \(0\)\
\-\ necrosis\\:\\ 0\\.0066662069435666094\ \(0\)\
\-\ 4\\.\\:\\ 0\\.00664916990197786\ \(0\)\
\-\ process\\:\\ 0\\.006502105701254376\ \(0\)\
\-\ structures\\:\\ 0\\.006502105701254376\ \(0\)\
\-\ pattern\\:\\ 0\\.006455419642433356\ \(0\)\
\-\ based\\:\\ 0\\.006440099530171858\ \(0\)\
\-\ \\,\\:\\ 0\\.006420001553769661\ \(0\)\
\-\ throughout\\:\\ 0\\.006321635032213294\ \(0\)\
\-\ pt\\:\\ 0\\.006278979752238641\ \(0\)\
\-\ laboratory\\:\\ 0\\.006223501454257047\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.006209871851373529\ \(0\)\
\-\ involvement\\:\\ 0\\.006189602088197265\ \(0\)\
\-\ wbc\\:\\ 0\\.006156274408252592\ \(0\)\
\-\ portion\\:\\ 0\\.006117009184504123\ \(0\)\
\-\ risk\\:\\ 0\\.006117009184504123\ \(0\)\
\-\ peripheral\\:\\ 0\\.006110540162083235\ \(0\)\
\-\ required\\:\\ 0\\.00607850891657562\ \(0\)\
\-\ sclerosis\\:\\ 0\\.006065840382265503\ \(0\)\
\-\ and\\:\\ 0\\.006047733394165442\ \(0\)\
\-\ being\\:\\ 0\\.0058849564758904314\ \(0\)\
\-\ given\\:\\ 0\\.005789356506949293\ \(0\)\
\-\ 3\\.\\:\\ 0\\.005778407533874955\ \(0\)\
\-\ week\\:\\ 0\\.005735208336617051\ \(0\)\
\-\ cause\\:\\ 0\\.005713957759984122\ \(0\)\
\-\ this\\:\\ 0\\.005698441976170749\ \(0\)\
\-\ extending\\:\\ 0\\.00567731037320118\ \(0\)\
\-\ recent\\:\\ 0\\.00567731037320118\ \(0\)\
\-\ space\\:\\ 0\\.005586081041653428\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.005494144251861149\ \(0\)\
\-\ body\\:\\ 0\\.005484710894642459\ \(0\)\
\-\ superior\\:\\ 0\\.00539277410485018\ \(0\)\
\-\ injury\\:\\ 0\\.0053838113476063236\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0053704429679847\ \(0\)\
\-\ radiographs\\:\\ 0\\.005348361346249274\ \(0\)\
\-\ known\\:\\ 0\\.00534397447522494\ \(0\)\
\-\ area\\:\\ 0\\.005339597320423452\ \(0\)\
\-\ 1\\.\\:\\ 0\\.005275077403750199\ \(0\)\
\-\ be\\:\\ 0\\.005208524598197348\ \(0\)\
\-\ clinical\\:\\ 0\\.005196264427007913\ \(0\)\
\-\ tenderness\\:\\ 0\\.005136190361426153\ \(0\)\
\-\ no\\:\\ 0\\.005101447533817007\ \(0\)\
\-\ month\\:\\ 0\\.005066431898815433\ \(0\)\
\-\ treated\\:\\ 0\\.005055041178031342\ \(0\)\
\-\ demonstrated\\:\\ 0\\.004955375459401121\ \(0\)\
\-\ two\\:\\ 0\\.004836622999241117\ \(0\)\
\-\ appearance\\:\\ 0\\.004829854894732493\ \(0\)\
\-\ abnormal\\:\\ 0\\.0048163878267093105\ \(0\)\
\-\ fluid\\:\\ 0\\.0047996820249088\ \(0\)\
\-\ following\\:\\ 0\\.004793039045259186\ \(0\)\
\-\ t2\\:\\ 0\\.004779819701087652\ \(0\)\
\-\ time\\:\\ 0\\.004769962899682435\ \(0\)\
\-\ secondary\\:\\ 0\\.004721403095867208\ \(0\)\
\-\ low\\:\\ 0\\.00469598429420237\ \(0\)\
\-\ y\\/o\\:\\ 0\\.004677132469999289\ \(0\)\
\-\ high\\:\\ 0\\.004621632531772363\ \(0\)\
\-\ been\\:\\ 0\\.0045944563032885195\ \(0\)\
\-\ one\\:\\ 0\\.004576544235791786\ \(0\)\
\-\ enhancement\\:\\ 0\\.004526657640559359\ \(0\)\
\-\ fracture\\:\\ 0\\.004452716067732764\ \(0\)\
\-\ the\\:\\ 0\\.004371518883909116\ \(0\)\
\-\ over\\:\\ 0\\.004299688913320084\ \(0\)\
\-\ acute\\:\\ 0\\.0041697219942816105\ \(0\)\
\-\ physical\\:\\ 0\\.004143291046603237\ \(0\)\
\-\ soft\\:\\ 0\\.004112503486153261\ \(0\)\
\-\ tissue\\:\\ 0\\.004002808672831213\ \(0\)\
\-\ imaging\\:\\ 0\\.003956667637264036\ \(0\)\
\-\ it\\:\\ 0\\.0037961430524367915\ \(0\)\
\-\ exam\\:\\ 0\\.0037099484979239883\ \(0\)\
\-\ lateral\\:\\ 0\\.00364954159214338\ \(0\)\
\-\ had\\:\\ 0\\.003643971974784008\ \(0\)\
\-\ surgical\\:\\ 0\\.0035498453957538605\ \(0\)\
\-\ presents\\:\\ 0\\.0034498899120709997\ \(0\)\
\-\ seen\\:\\ 0\\.0033372087254302176\ \(0\)\
\-\ is\\:\\ 0\\.003333739792794816\ \(0\)\
\-\ also\\:\\ 0\\.0033292877345259906\ \(0\)\
\-\ images\\:\\ 0\\.0032396519603742173\ \(0\)\
\-\ of\\:\\ 0\\.003223425318521419\ \(0\)\
\-\ has\\:\\ 0\\.003171343815206083\ \(0\)\
\-\ which\\:\\ 0\\.003152459658582112\ \(0\)\
\-\ that\\:\\ 0\\.002916957961578702\ \(0\)\
\-\ \\(\\:\\ 0\\.002855184688710911\ \(0\)\
\-\ \\)\\:\\ 0\\.0028203070834517986\ \(0\)\
\-\ normal\\:\\ 0\\.002647455443871741\ \(0\)\
\-\ there\\:\\ 0\\.002513271850721321\ \(0\)\
\-\ ct\\:\\ 0\\.0023622601845692546\ \(0\)\
\-\ an\\:\\ 0\\.0023353060558986755\ \(0\)\
\-\ at\\:\\ 0\\.0022880694719992745\ \(0\)\
\-\ \\:\\:\\ 0\\.0022337446956337253\ \(0\)\
\-\ or\\:\\ 0\\.001979293970284007\ \(0\)\
\-\ \\.\\:\\ 0\\.001964401206967778\ \(0\)\
\-\ year\\:\\ 0\\.0018895361052824401\ \(0\)\
\-\ patient\\:\\ 0\\.0016928694286885136\ \(0\)\
\-\ with\\:\\ 0\\.0016186348470933363\ \(0\)\
\-\ a\\:\\ 0\\.0007837940747403186\ \(0\)\
